Recent studies, adverse event data, and ongoing litigation indicate a potential connection between ozempic and vision loss , particularly a condition known as: NAION (non-arteritic anterior ischemic optic neuropathy) is a serious eye condition caused by reduced blood flow to the optic nerve
GLP-1 medications may indirectly improve ED by tackling obesity and its related health problems
By utilizing a dose-response and a time-course approach, Marcus et al
Conditions treated with Saxenda and Victoza So, what do Saxenda and Victoza treat
Semaglutide exhibits approximately 3-fold greater potency at GLP-1 receptors than liraglutide, resulting in lower required doses for comparable glycemic effects
However, if your primary concern is weight loss due to obesity or being overweight, Wegovy or Zepbound might be the better option